Clinical Trial Update: Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating brain protection with selective head cooling and dexmedetomidine in liver transplant patients; status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Complications

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Selective head cooling

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Liver Transplant; Complications | Phase 2 | Status: UNKNOWN